ArticleAdvanced healthcare materials2021

Plasmonically Enhanced CRISPR/Cas13a-Based Bioassay for Amplification-Free Detection of Cancer-Associated RNA.

Lin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.